Ftse Mib
34.339,32
0,00%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.895,23
-0,24%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Syneron Medical Ltd. - Ordinary Shares (ELOS) Syneron Medical Ltd. - Ordinary Shares (ELOS) Notizie

ELOS

Syneron Medical Ltd. - Ordinary Shares (ELOS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELOS
DataOraFonteTitoloSimboloCompagnia
01/08/201715:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/07/201715:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201716:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201714:51Edgar (US Regulatory)(25-NSE)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201713:46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201713:30PR Newswire (US)Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private CompanyNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/07/201717:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/06/201715:22PR Newswire (US)Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax PartnersNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/05/201714:37Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/05/201723:00PR Newswire (US)Syneron Medical Reports First Quarter 2017 Revenue of $66.9 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201712:13Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201712:00PR Newswire (US)Syneron Candela Announces End of Go-Shop PeriodNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
03/04/201718:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/03/201710:00PR Newswire (US)Syneron Candela Announces CE Mark for CO2RE® IntimaNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201721:10PR Newswire (US)Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its WebsiteNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201720:43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
20/03/201721:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
01/03/201721:05PR Newswire (US)Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual MeetingNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/02/201713:00PR Newswire (US)Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
13/02/201715:00PR Newswire (US)Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare ConferenceNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/02/201715:00GlobeNewswire Inc.Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of DirectorsNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
31/01/201722:05PR Newswire (US)Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources OfficerNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
30/01/201715:00PR Newswire (US)Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
11/11/201622:00PR Newswire (US)Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics ForumNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
09/11/201613:00PR Newswire (US)Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/11/201615:00PR Newswire (US)Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term...NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201621:09Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201613:00PR Newswire (US)Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 RevenueNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/09/201622:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
04/08/201613:00PR Newswire (US)Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELOS

La tua Cronologia

BIT
11COV
Covestro
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network